Table 7.
Relationship among clinical variables and adequacy of management and pain interference at the oncology unit of ACSH, Mekelle, Ethiopia (n = 91).
| Adequacy of treatment, n (%) | Association | Pain functioning interference, n (%) | Association | ||||
|---|---|---|---|---|---|---|---|
| Adequate | Inadequate | X2, p value | No/mild | Moderate/severe | X2, p value | ||
| Type of patient status | 0.167, 0.683 | 7.173, 0.007∗∗ | |||||
| Admitted | 46 (50.5) | 35 (38.5) | 17 (18.7) | 64 (70.3) | |||
| Ambulatory | 5 (5.5) | 5 (5.5) | 6 (6.6) | 4 (4.4) | |||
|
| |||||||
| Site of cancer | 11.581, 0.072 | 12.092, 0.600 | |||||
| Genitourinary cancer | 5 (5.5) | 12 (13.2) | 7 (7.7) | 10 (11.0) | |||
| Gastrointestinal cancer | 11 (12.1) | 13 (14.3) | 10 (11.0) | 14 (15.4) | |||
| Breast cancer | 3 (3.3) | 1 (1.1) | 0 (0) | 4 (4.4) | |||
| Head and neck cancer | 9 (9.9) | 3 (3.3) | 1 (1.1) | 11 (12.1) | |||
| Bronchopulmonary cancer | 8 (8.8) | 5 (5.5.) | 1 (1.1) | 12 (13.2) | |||
| Follicular lymphoma | 3 (3.3) | 0 (0) | 0 (0) | 3 (3.3) | |||
| Others | 12 (13.2) | 6 (6.6) | 4 (4.4) | 14 (15.4) | |||
| Stage of tumor | 0.467, 0.792 | 1.902, 0.386 | |||||
| Stage II | 11 (12.1) | 9 (9.9) | 7 (7.7) | 13 (14.3) | |||
| Stage III | 20 (22.0) | 18 (19.8) | 10 (11.0) | 28 (70.8) | |||
| Stage IV | 20 (22.0) | 13 (14.3) | 6 (6.6) | 27 (29.7) | |||
|
| |||||||
| Metastasis | 1.566, 0.457 | 7.459, 0.024∗ | |||||
| Present | 22 (24.2) | 19 (20.9) | 5 (5.5) | 36 (39.6) | |||
| Absent | 29 (31.9) | 20 (22.0) | 18 (19.8) | 31 (34.1) | |||
|
| |||||||
| History of treatment modality | 1.839, 0.175 | 1.113, 0.292 | |||||
| Chemotherapy | 21 (23.1) | 11 (12.1) | 6 (6.6) | 26 (28.6) | |||
| Chemotherapy + surgery | 30 (33.0) | 29 (31.9) | 17 (18.7) | 42 (46.2) | |||
|
| |||||||
| Comorbidity | 5.038, 0.025∗ | 0.252, 0.616 | |||||
| Present | 6 (6.6) | 0 (0) | 1 (1.1) | 5 (5.5) | |||
| Absent | 45 (49.5) | 40 (44.0) | 22 (24.2) | 63 (69.2) | |||
∗∗Significant at p < 0.01; ∗significant at p < 0.05.